SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
824 29 0 ALXN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
749Clearly, ALXN, its backers and investors have taken a huge risk. Surely, the coIan@SI-3/20/2007
748Pricing is outrageous. And supposedly mfg costs have come way down in general, srkrw-3/20/2007
747Just one moderate president away from changing orphan drug economics....keokalani'nui-3/20/2007
746This always bothered me most about GENZ to be honest. JonRobohogs-3/20/2007
745Ethics and doing the right thing is a rarity. If they price at less than $300K irkrw-3/20/2007
744For the sake of the patients, the company, its shareholders, the industry and makeokalani'nui-3/20/2007
743For Alexion, Third Time's The Charm Matthew Herper, 03.16.07, 2:45 PM ET AlIcebrg-3/20/2007
742Item 8.01 Other Events. Marketing Approval On March 16, 2007, Alexion PharmaceIcebrg-3/19/2007
741Only this headline so far? Alexion:Research Foundation Sues Co, Alleges ContracLJM-3/19/2007
740ALXN is ready to fight it. Or at least that is what they are saying.kenhott-3/19/2007
739Form 8-K for PDL BIOPHARMA, INC. 19-Mar-2007 Other Events Item 8.01. Other Evnigel bates-3/19/2007
738Sales and marketing CC next monday, didn't give out any sales info on today&kenhott-3/19/2007
737Update: FDA Approves Alexion's Soliris(TM) for All Patients With PNH Monday kenhott-3/19/2007
736I think they pretty much got the label they wanted. Conference call Monday.kenhott-3/18/2007
735Anybody know if label includes transfusion independent pts? No mention in PR.keokalani'nui-3/16/2007
734fda.gov FDA Approves First-of-its-Kind Drug to Treat Rare Blood Disorder The Ukenhott-3/16/2007
733(Soliris approved) WASHINGTON, March 16 (Reuters) - Alexion Pharmaceuticals, Inckeokalani'nui-3/16/2007
732William Blair & Company Initiates Coverage of Alexion Pharmaceuticals, Inc. Icebrg-3/8/2007
731You are right. If they don't get taken out, they will need to go outside fokenhott-2/27/2007
730Soliris was more or less their last chance of a shot on goal. The pipeline now lIcebrg-2/26/2007
729yep, valueline (eom)mopgcw-2/26/2007
728VL is valueline? <2009-11 PROJECTED VALUATION Revenues: $650 mill. Shs outstkenhott-2/26/2007
727VL: Alexion Pharmaceuticals, Inc. BASIS FOR BUY/HOLD RECOMMENDATION Alexion Phamopgcw-2/25/2007
726I should have known you back when it was in the 20's<G>tom pope-12/16/2006
725Hello Tom, Back when the long time ALXN investors used to inhabit the Yahoo mesrareearth42-12/16/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News